To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non–Small Cell Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology
Reference126 articles.
1. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients;Blomgren;Acta Oncol,1995
2. Limited field irradiation in early stage (T1-2N0) non–small cell lung cancer;Slotman;Radiother Oncol,1996
3. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2002
4. Computed tomography-guided frameless stereotactic radiotherapy for stage I non–small cell lung cancer: A 5-year experience;Uematsu;Int J Radiat Oncol Biol Phys,2001
5. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas;Fukumoto;Cancer,2002
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2023-11
2. Clinical Factors That Affect Fiducial Tracking in Robotic SABR for Lung Tumors;Advances in Radiation Oncology;2023-11
3. Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia;Clinical and Translational Radiation Oncology;2022-05
4. A cycle generative adversarial network for improving the quality of four-dimensional cone-beam computed tomography images;Radiation Oncology;2022-04-07
5. Novel Radiation Therapy Paradigms and Immunomodulation: Heresies and Hope;Seminars in Radiation Oncology;2020-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3